TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver

Huailin Deng1, Ruiqiu Zhang2

  • 1Graduate School of Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

Metabolites
|May 26, 2026
PubMed

Insights

Chinese herbal monomers show promise for treating metabolic dysfunction-associated steatotic liver disease (MASLD) by improving gut health and inflammation. Further research is needed to clarify their long-term safety and clinical application for MASLD.

Area of Science:

  • Pharmacology and Toxicology
  • Gastroenterology
  • Integrative Medicine

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to gut microbiota imbalance and gut-liver axis dysfunction.
  • Chinese herbal monomers offer multi-target benefits for MASLD, particularly in microecological intervention.
  • Toxicity and safety research for these monomers lag, hindering clinical translation.

Purpose of the Study:

  • To systematically review the toxicological perspective of Chinese herbal monomers in treating MASLD.
  • To analyze their mechanisms including gut microbiota modulation, barrier repair, and metabolic regulation.
  • To discuss limitations and translational bottlenecks for clinical application.

Main Methods:

  • Review of research on flavonoids, triterpenoids, alkaloids, and polysaccharides.
  • Analysis of toxicological data and mechanisms of action.
  • Integration of multi-omics approaches (16S rRNA, metagenomics, metabolomics).

Main Results:

  • Herbal monomers reshape gut microbiota, repair intestinal barrier, and regulate SCFA/bile acid metabolism.
  • They modulate key signaling pathways (TLR4/NF-kB, FXR, TGR5, SIRT1, NLRP3 inflammasome).
  • A three-in-one advantage of microecological remodeling, metabolic regulation, and inflammation inhibition is evident.

Conclusions:

  • Chinese herbal monomers present a promising therapeutic strategy for MASLD.
  • Further research is crucial to address long-term safety, dose-effect relationships, and drug interactions.
  • Clarifying toxicological profiles is essential for successful clinical translation.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...